Skip to content
Open access

An Engineered Biomimetic Nanoreactor With Cascade Functions for Targeted and Combinatorial Therapy of Ischemic Stroke

Sep 2026 · Advanced Healthcare Materials · Vol 15 · 0 citations · 46 references
Medicine

Abstract

Ischemic stroke reperfusion injury is driven by oxidative stress and neuroinflammation, but current neuroprotective strategies suffer from poor targeting, limited functionality, and low blood‑‐brain barrier (BBB) penetration. Herein, a multifunctional nanoplatform (RM@HPAN) is constructed: a hollow mesoporous Prussian blue core with multi‑enzyme mimetic activity, loaded with L‑arginine and butylphthalide, cloaked with red blood cell membrane for immune evasion, and modified with RVG‑29 for brain targeting. RM@HPAN exhibits ideal nanosize, pH‑responsive release, and robust ROS scavenging. It crosses a BBB model in vitro and boosts neuronal viability under oxygen‑‐glucose deprivation/reoxygenation. In a mouse middle cerebral artery occlusion model, RM@HPAN targets ischemic regions, reduces infarct volume from 29.4% to 3.8%, improves neurological scores, and rebalances inflammatory cytokines (TNF‑α, IL‑6, IL‑10, TGF‑β1). Transcriptomic and proteomic analyses reveal that RM@HPAN suppresses cytokine‑cytokine receptor interaction and TNF signaling while activating Rap1/PI3K/Akt and Nrf2/HO‑1 pathways, thereby inhibiting apoptosis and oxidative stress. Biosafety assessments confirm good biocompatibility. Thus, RM@HPAN offers a promising translatable strategy for ischemic stroke.

Read PDF

Similar papers

#diffusion models Review Open access Aug 2026

Carbon dots as a smart nanoplatform for the blood‐brain barrier penetration and ischemic stroke therapy

Ischemic stroke (IS) is one of the primary causes of global mortality and permanent neurological disability, and its clinical treatment is severely constrained by the intricate ischemic pathological cascade and the impermeable blood‐brain barrier (BBB). Cerebral ischemia and reperfusion trigger a series of pathologic...

Yan-Han Huang, Xuan Hou, Haiping Zhao et al. · 0 citations
Sep 2026

A Brain-Targeted Nanozyme System for Alleviating Poststroke Neuroinflammation via Synergistic Antioxidant and Anti-inflammatory Mechanisms.

Ischemic stroke (IS) is severely aggravated by oxidative stress and neuroinflammation, while the blood-brain barrier (BBB) poses a major obstacle to effective therapy. Herein, we developed a brain-targeted nanozyme system (TLNP@Pt/Fe3O4) by encapsulating Pt/Fe3O4 nanozymes into T7 peptide-modified lipid nanoparticles....

Bo-Yang Wei, Yu Wu, Jia-Ming Zhou et al. · 0 citations
Review Open access Aug 2026

Stimuli-responsive nanozyme-hydrogel systems for ischemic stroke: toward spatiotemporal catalytic control of the neurovascular unit

There is limited direct evidence of fully integrated nanozyme-hydrogel platforms specifically for stroke; the field largely relies on the intersection of advanced stroke nanozymes and responsive hydrogels.

Sen Yan, Xiao-Hong Wang, Cai Li et al. · 0 citations
Sep 2026

Magnetic Hydrogels Deliver H 2 Se Spatiotemporally to Remodel the Regenerative Microenvironment and Accelerate Peripheral Nerve Repair

A repair system based on magnetothermal controlled release of hydrogen selenide achieved nerve regeneration and functional recovery comparable to autologous grafts in rats, and offers a promising approach for neural repair.

Xin-Yue Liang, Jun-Wei Su, Jun-Wei Yang et al. · 0 citations
Aug 2026

RVG‐Functionalized Liposomal Mollugin: A Targeted Nanotherapy for Spinal Cord Injury

A RVG‐modified liposomal nanoplatform for targeted delivery of mollugin (Mol@Lip‐RVG) as a novel therapeutic strategy for SCI resulted in enhanced neuro‐preservation and substantial improvement in motor function recovery, achieved through dual modulation of microglial reprogramming and attenuation of oxidative stress.

Quan Zhou, I. Shaikh, Jian-Feng Wang et al. · 0 citations
Aug 2026

Ultrasound-Programmable ROS-Responsive Hydrogel Orchestrates Staged Immunomodulation and Neurorepair after Intracerebral Hemorrhage.

An ultrasound-actuated, injectable ROS-scavenging hydrogel platform enabling sequential IL-4/NT-3 delivery provides a minimally invasive platform for phase-adapted intervention in hemorrhagic brain injury.

Ruiying Han, Yun-Sen He, Yong-Lin He et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.